Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kenney

Showing results (281-290 of 304) with videos related to

Pageof 31
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expressionChunyan Wang, Jillian A Bristol, Scott E Nelson, et al.
Organic Letters|November 26, 2019
Boron-Templated Dimerization of Allylic Alcohols To Form Protected 1,3-Diols via Acid CatalysisS Hadi Nazari, Kelton G Forson, Erin E Martinez, et al.
The Journal of Clinical Investigation|December 9, 2014
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesisShi-Dong Ma, Xuequn Xu, Julie Plowshay, et al.
The Journal of Investigative Dermatology|October 26, 2012
MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repairNeehar Bhatia, Tony Z Xiao, Kimberly A Rosenthal, et al.
The Lancet. Neurology|September 20, 2025
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosisShiv Saidha, Ari J Green, Letizia Leocani, et al.
Journal of Virology|October 29, 2010
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomasShi-Dong Ma, Subramanya Hegde, Ken H Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2016
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros ExpressionRichard J Jones, Tawin Iempridee, Xiaobin Wang, et al.
Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Pageof 31

Showing results (281-290 of 304) with videos related to

Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|May 26, 2026
Epstein-Barr virus (EBV) infection causes human germinal center B cell-derived lymphomas in the absence of EBNA2 expressionChunyan Wang, Jillian A Bristol, Scott E Nelson, et al.
Organic Letters|November 26, 2019
Boron-Templated Dimerization of Allylic Alcohols To Form Protected 1,3-Diols via Acid CatalysisS Hadi Nazari, Kelton G Forson, Erin E Martinez, et al.
The Journal of Clinical Investigation|December 9, 2014
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesisShi-Dong Ma, Xuequn Xu, Julie Plowshay, et al.
The Journal of Investigative Dermatology|October 26, 2012
MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repairNeehar Bhatia, Tony Z Xiao, Kimberly A Rosenthal, et al.
The Lancet. Neurology|September 20, 2025
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosisShiv Saidha, Ari J Green, Letizia Leocani, et al.
Journal of Virology|October 29, 2010
A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomasShi-Dong Ma, Subramanya Hegde, Ken H Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2016
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros ExpressionRichard J Jones, Tawin Iempridee, Xiaobin Wang, et al.
Mbio|August 22, 2019
Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell CycleMark R Eichelberg, Rene Welch, J Tod Guidry, et al.
Plos Pathogens|June 17, 2020
EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized miceChunrong Li, James C Romero-Masters, Shane Huebner, et al.
Plos Pathogens|July 28, 2018
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionJillian A Bristol, Reza Djavadian, Emily R Albright, et al.
Pageof 31